We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Protein Crystals Used to Prepare Cellular Drug Delivery Nanotubes

By LabMedica International staff writers
Posted on 28 Nov 2018
Print article
Image: The method for assembly of protein nanotubes involved a four-step process: 1) introduction of cysteine residues into the wild-type protein; 2) crystallization of the engineered protein into a lattice structure; 3) formation of a cross-linked crystal; and 4) dissolution of the scaffold to release the protein nanotubes (Photo courtesy of Chemical Science).
Image: The method for assembly of protein nanotubes involved a four-step process: 1) introduction of cysteine residues into the wild-type protein; 2) crystallization of the engineered protein into a lattice structure; 3) formation of a cross-linked crystal; and 4) dissolution of the scaffold to release the protein nanotubes (Photo courtesy of Chemical Science).
A team of Japanese biomolecular engineers used scaffolds of cross-linked protein crystals to prepare nanotubes, which are structures that can serve as the basis for minute delivery systems for drugs and other substances.

Investigators at the Tokyo Institute of Technology (Japan) reported in the October 30, 2018, online edition of the journal Chemical Science that they had developed a new method for preparing nano-size structures using protein crystals as non-equilibrium molecular scaffolds. Protein crystals were found to provide an ideal environment with a highly ordered packing of subunits in which the supramolecular assembled structures formed in the crystalline matrix.

The investigators used the protein RubisCO (Ribulose-1,5-bisphosphate carboxylase/oxygenase) as the building block for construction of the nanotubes. This protein was selected for its high stability, which enabled it to retain its shape and crystal structure.

As described, the method comprised four steps: (1) Preparation of an engineered protein; (2) formation of the protein crystal scaffold; (3) formation of a cross-linked crystal; (4) release of the protein nanotubes by dissolving the scaffold. The assembly of tubes was driven by the formation of disulfide bonds to retain the intermolecular interactions within each assembly in the crystalline matrix after dissolution of the crystals. Transmission electron microscopy (TEM) was used to confirm the formation of the protein nanotubes.

"Our cross-linking method can facilitate the formation of the crystal scaffold efficiently at the desired position (specific cysteine sites) within each tube of the crystal," said senior author Dr. Takafumi Ueno, professor of biomolecular engineering at the Tokyo Institute of Technology. "At present, since more than 100,000 protein crystal structures have been deposited in protein data bank, our method can be applied to other protein crystals for construction of supramolecular protein assemblies, such as cages, tubes, sheets."

Related Links:
Tokyo Institute of Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more